July 26, 2022
One of the former Insys executives convicted in an opioid kickback scheme told a Boston federal court that he should be granted compassionate release from prison, saying in a court filing that his continued incarceration is "baffling but not surprising."
November 24, 2021
Federal prosecutors in the Insys Therapeutics Inc. opioid kickback case won a fight over how much the founder and former executives owe victims, as a Boston federal judge on Tuesday ordered up the $48.3 million restitution sum requested by the government.
October 26, 2021
Insys Therapeutics Inc. founder John Kapoor and fellow former executives should pay the full $48.3 million they owe to the victims of their opioid kickback scheme, prosecutors argued in a hearing Tuesday, because the now-bankrupt company was lying to insurers "all day, every day."
October 22, 2021
Former Insys Therapeutics Inc. CEO Michael Babich saw his prison term for his role in the company's scheme to bribe doctors to prescribe a powerful opioid spray trimmed from 30 months to 22 months Friday.
October 15, 2021
The convicted founder of Insys Therapeutics Inc. on Thursday asked a Boston federal judge to cut $24 million from what he owes victims, saying the First Circuit's instructions after overturning the initial restitution sum requires a new number more closely tailored to the alleged fraud.
March 31, 2021
A recent Fifth Circuit ruling scrapping a conviction for a lesser player in a fraud scheme will not keep former Insys Therapeutics Inc. executive Sunrise Lee out of prison during her appeal, after a judge ruled Wednesday there is plenty of proof to link Lee to the opioid company's wrongdoing.
March 30, 2021
A convicted former Insys Therapeutics executive can postpone his prison sentence until he gets his second COVID-19 vaccine dose later next month, but he won't be allowed a longer delay to care for his terminally ill mother, a Massachusetts federal judge said Tuesday.
March 26, 2021
Former Insys Therapeutics Inc. manager Sunrise Lee, convicted in an opioid kickback scheme, argued Friday that a recent Fifth Circuit ruling upping the burden of proof for lesser players in a scheme should keep her out of prison until the First Circuit hears her appeal.
March 18, 2021
Even as he acknowledged a judge's warning that further prison delays are unlikely, a former Insys Therapeutics Inc. executive convicted in an opioid kickback scheme asked for a 60-day postponement Thursday on the grounds that he has not been vaccinated against COVID-19 and his mother is terminally ill.
January 25, 2021
Insys Therapeutics Inc. founder John Kapoor and five of his former underlings can put off reporting to prison until April after a federal judge granted a seventh postponement Monday, citing the ongoing COVID-19 pandemic and suggesting this delay will be the last.